Matches 1 - 50 out of 278 1 2 3 4 5 6 >
Match Document Document Title
7488724 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors  
The invention provides compounds of formula (I): wherein: R 1 -R 4 and A have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for...
7485632 Cephalosporins  
A compound of formula wherein the substituents have various meanings, useful as a pharmaceutical.
7384928 Broad spectrum cephem compounds  
A compound of the formula: (wherein, T is S, SO or O; X is halogen, CN, carbamoyl optionally substituted with lower alkyl, lower alkyl, lower alkoxy, or lower alkylthio; A is substituted lower...
7378408 Methods of treatment and formulations of cephalosporin  
Formulations containing an antibacterial alkali metal salt of a cephalosporin compound and methods of treating bacterial infections in dogs and cats.
7351419 Oral pharmaceutical suspension of Cefdinir crystal  
The present invention relates to a novel oral pharmaceutical suspension of Cefdinir crystal. More specifically, the present invention relates to a novel kit for preparation of an oral...
7341993 Cross-linked glycopeptide—cephalosporin antibiotics  
This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical...
7192943 Cephem compounds  
The present invention relates to a compound of the formula [I]: wherein R 1 is lower alkyl or hydroxy(lower)alkyl, and R 2 is hydrogen or amino protecting group, or R 1 and R 2 are bonded...
7179801 Cephem compounds  
The present invention relates to a compound of the formula [I]: wherein A is lower alkylene or lower alkenylene; R 1 is lower alkyl, hydroxy(lower)alkyl, protected hydroxy(lower)alkyl,...
7129232 Cephem compounds  
The present invention relates to a compound of the formula [I]: wherein R 1 is lower alkyl, hydroxy(lower)alkyl or halo(lower)alkyl, and R 2 is hydrogen or amino protecting group, or R...
7115624 Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48  
The present invention provides a method of inhibiting a member of a family of Protein Tyrosine Phosphatases (PTPases, PTPs) such as PTP1B, TC-PTP, CD45, SHP-1, SHP-2, PTPα, PTPε, PTPμ, PTPδ,...
7094431 Method of healing skin wounds in mammals and a composition therefor  
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or...
6916801 7-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitors  
The invention provides compounds of formula (I): wherein: R 1 -R 4 and A have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for...
6911441 Prolonged release pharmaceutical composition  
Novel pharmaceutical compositions of a cephalosporin in a prolonged release vehicle, comprising an oil and aluminium distearate, provide a prolonged duration of effective blood-plasma concentration...
6906054 Compositions for inhibiting beta-lactamase  
The invention provides pharmaceutical compositions comprising compounds of formula I and IV: wherein R 1 -R 11 and A have any of the values defined in the specification, and their...
6727243 Compositions comprising cefuroxime axetil  
Cefuroxime axetil in a non-gelatinous form on contact with an aqueous liquid, e.g., in the form of a solid dispersion on a carrier, e.g., useful for the production of pharmaceutical compositions...
6693095 Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates  
A compound of formula wherein W, V, R 1 , R 5 , R 2 , R 3 and R 4 have various meanings, a process for their production and their use as a pharmaceutical.
6583133 Propenyl cephalosporin derivatives and process for the manufacture thereof  
Disclosed are cephalosporin derivatives of the general formula wherein R is an organic residue with a molecular weight not exceeding 400 bonded to the adjacent sulphur atom via carbon and...
6534494 Process for the preparation of cefuroxime axetil in an amorphous form  
A process for preparing cefuroxime axetil in substantially amorphous form comprises forming a mixture of crystalline cefuroxime axetil and at least one pharmaceutically acceptable excipient, and...
6486149 Composition comprising a crystallographically stable, amorphous cephalosporin and processes for the preparation thereof  
Processes are provided for the preparation of orally administrable, yellow and powdery compositions essentially consisting of particles composed of a homogeneous mixture of an amorphous Cefditoren...
6465428 Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime  
The present invention relates to pharmaceutical combinations of group A and group B streptogramins, in particular to combinations of dalfopristine and quinupristine, with cefepime, which...
6407091 β-lactamase inhibiting compounds  
The invention provides compounds of formula I and IV: wherein R 1 -R 11 and A have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for...
6342493 Crystallographically stable amorphous cephalosporin compositions and process for producing the same  
Processes are provided for the preparation of orally administrable, yellow and powdery compositions essentially consisting of particles composed of a homogeneous mixture of an amorphous Cefditoren...
6323193 Bioavailable oral dosage form of cefuroxime axetil  
This invention relates to a bioavailable oral dosage form comprising of amorphous cefuroxime axetil containing from 7 to 25% crystalline cefuroxime axetil.
6300347 2-substituted 4,5-diaryl imidazoles  
Novel 2-substituted 4,5-diaryl imidazoles are provided, in particular compounds of Formula I ##STR1## wherein R1, R2, R3 and R4 are as defined, in free or pharmaceutically-acceptable acid addition...
6262044 Modulators of protein tyrosine phosphatases (PTPASES)  
The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein...
6232306 Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephams  
The present invention provides compounds of formula I ##STR1## wherein R 1 is hydrogen, C 1 -6 -alkyl, C 1 -6 -alkyl substituted by fluoro, or C 3 -6 -cycloalkyl; R 2 is hydrogen or a...
6180621 Method and treatment using 1-methylcarbapenem derivatives as an anti-helicobacter pylori agent  
A method for the prophylaxis or treatment of infectious diseases caused by helicobacter pyloir, by administering a pharmacologically effective amount of a 1-methoylcarbapenem coumpund of formula...
6150350 Antimicrobial compositions  
The invention relates to antimicrobial compositions comprising a combination of (1) a therapeutically effective amount of a compound of formula I ##STR1## with (2) a second ingredient selected from...
6063778 Cephalosporin derivatives and processes for the preparation thereof  
The invention provides novel cephalosporin derivatives of the formula (I) ##STR1## and salts thereof for use in pharmaceutical compositions. Also novel precursors for synthesis of the...
6020329 Cephaloporins and homologues, preparations and pharmaceutical compositions  
β-Lactam antibiotics of formula (I) or a salt thereof, wherein R 1 is hydrogen, methoxy or formamido; R 2 is an acy group; CO 2 R 3 is a carboxy group or a carboxylate anion, or R 3 is a...
6013647 Benzoxazinedione derivatives, method of producing them and uses thereof  
This invention relates to new benzoxazinedione derivatives corresponding to the formula I: ##STR1## wherein R 1 =H or carboxyalkyl, R 2 =H, alkyl or phenyl, and R 3 represents different acid...
5994340 Azetidinone derivatives as β-lactamase inhibitors  
New 2-oxo-1-azetidine sulfonic acid derivatives with an aminoalkyl substituted "anti" (E-isomer) oxyimino group in the acylamino substituent at the 3 position of the monobactam ring. These...
5981519 Vinyl-pyrrolidinone cephalosporins  
The present invention relates to compounds having the formula ##STR1## wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are as defined herein as well as readily hydrolyzable esters thereof,...
5925632 Derivatives of 3-pyrrolidylidene-2-one-cephalsporines  
Compounds of formula (I) ##STR1## wherein R 1 is hydrogen, lower alkyl, aralkyl, cycloalkyl, R 3 CO-- or --C(R 4 R 5 )CO 2 R 6 ; where R 4 and R 5 are each independently hydrogen or lower...
5856320 Cephem compounds, their preparation and their use as antimicrobial agents  
Novel cephalosporin derivatives of formula (II): ##STR1## wherein R 2 is hydrogen, methyl, or fluoromethyl; R 3 is hydrogen, methyl or carboxyl; R 4 is hydrogen or methyl; A is methylene or...
5843937 DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents  
The present invention relates to novel DNA alkylating agents and the prodrugs of these agents which are useful as antitumor agents and DNA labelling agents. The compounds are hydroxy...
5804577 Cephalosporin derivatives  
The present invention relates to compounds of formula I ##STR1## wherein R 1 is a group selected from 2-, 3-, and 4-hydroxyphenyl, 3-nitrophenyl, and 3-fluoro-4-hydroxyphenyl; as well as readily...
5760027 Use of 7-alkylidene cephalosporins to inhibit elastase activity  
The present invention relates to the use of 7-alkylidene derivatives of cephalosporin esters, such as sulfides, sulfoxides, and sulfones, as inhibitors of human leukocyte elastase. These materials...
5753667 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application  
The present invention provides a compound of formula (I) ##STR1## in which R 1 represents a hydrogen atom or a (C 1 -C 4 )alkyl group, R 2 represents a hydrogen atom or a straight or branched (C...
5747484 Crystalline cepham acid addition salts and processes for their preparation  
Novel crystalline cephem acid addition salts and processes for their preparation Compounds of the formula I ##STR1## in which n is equal to 1 or 2 and m is 0.4-2.6, and where X is the anion...
5728691 Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them  
Derivatives of 7-aminoceph-3-em-4-carboxylic acid with 6-fluoroquinolone derivatives in which the cephem and 6-fluoroquinolone moieties are bound to each other through a carboxamido bond as well as...
5721229 Soluble forms of cephalosporins and treatment of animals  
A dry solid mixture of a hydroxypolycarboxylic acid and a cephalosporin where the hydroxypolycarboxylic acid of the formula ##STR1## where x and y are 0 or 1 and z is 0 to 3, in the weight ration...
5710147 7-benzyloxyimino-cephalosporins  
The syn isomer of (R) or (S) or (R,S) mixture, in the form of internal salts or salts with acids or bases of a compound of the formula ##STR1## wherein the substituents are defined as in the...
5710146 Cephem derivatives and processes for their manufacture  
Cephem derivatives of the general formula ##STR1## in which the R 2 O group is in the syn-position, a process for their manufacture and pharmaceutical formulations which are active against...
5663163 Cephem compounds and processes for preparation thereof  
The present invention relates to new cephem compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same and anti-bacterial methods of using the same. The...
5663162 Cephem derivatives  
Compounds represented by the following formula (I), that is, cephem derivatives having substituted or unsubstituted imidazo[5,1-b]thiazolium-6-yl as a substituent at the 3-position of the cephem...
5661144 Cephem derivatives with 3-substituted bis heterocycles  
Compounds represented by the following formula (I), that is, cephem derivatives having substituted or unsubstituted 3-(imidazo[5,1-b]thiazolium-6-yl)-1-propenyl as a substituent at the 3-position...
5656623 Antimicrobial lactam-quinolones  
Antimicrobial lactam-quinolone compounds comprising a lactam-containing moiety linked to a quinolone moiety, of the formula: ##STR1## wherein (1) A 1 , A 2 , A 3 , R 1 , R 4 and R 6 generally...
5620968 7-substituted-amino-3-substituted-3-cephem-4-carboxylic acids  
The invention provides compounds of the formula: ##STR1## wherein the variables are hereinbelow described; and salts thereof. Also, pharmaceutical formulations and methods for treating bacterial...
5602117 Cephalosporin compounds  
β-lactam antibiotics of formula (I) or a salt thereof, wherein R 1 is hydrogen, methoxy of formamido; R 2 is an acyl group, in particular that of an antibacterially active cephalosporin; CO 2 R...
Matches 1 - 50 out of 278 1 2 3 4 5 6 >